A superparamagnetic polymersome with extremely high T2 relaxivity for MRI and cancer-targeted drug delivery
A superparamagnetic polymersome with extremely high T2 relaxivity for MRI and cancer-targeted drug delivery
复制标题
具有极高 T2 弛豫度的超顺磁性聚合物囊泡,适用于 MRI 和癌症靶向药物输送。
DOI:
10.1016/j.biomaterials.2016.10.027
复制
发表时间:
2017-01-01
期刊:
影响因子:
14
通讯作者:
Du, Jianzhong
中科院分区:
文献类型:
--
作者:
Liu, Qiuming;Song, Liwen;Du, Jianzhong
Improving the relaxivity of magnetic resonance imaging (MRI) contrast agents is an important challenge for cancer theranostics. Herein we report the design, synthesis, characterization, theoretical analysis and in vivo tests of a superparamagnetic polymersome as a new MRI contrast agent with extremely high T-2 relaxivity (611.6 mM(-1)s(-1)). First, a noncytotoxic cancer-targeting polymersome is synthesized based on a biodegradable diblock copolymer, folic acid-poly(L-glutamic acid)-block-poly(epsilon-caprolactone) [FA-PGA-b-PCL]. Then, ultra-small superparamagnetic iron oxide nanoparticles (SPIONs) are in situ generated in the hydrophilic PGA coronas of polymersomes to afford magnetic polymersomes. The in vivo MRI assay revealed prominent negative contrast enhancement of magnetic polymersomes at a very low Fe dose of 0.011 mmol/kg. Moreover, this cancer-targeting magnetic polymersome can effectively encapsulate and deliver anticancer drug to inhibit the tumor growth, demonstrating promising theranostic applications in biomedicine. (C) 2016 Elsevier Ltd. All rights reserved.